Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism
Lisa M Caronia, Andrew A Dwyer, Douglas Hayden, Francesca Amati, Nelly Pitteloud, Frances J Hayes, Lisa M Caronia, Andrew A Dwyer, Douglas Hayden, Francesca Amati, Nelly Pitteloud, Frances J Hayes
Abstract
Objective: This study examines the physiological impact of a glucose load on serum testosterone (T) levels in men with varying glucose tolerance (GT).
Design: Cross-sectional study.
Patients and methods: 74 men (19-74 years, mean 51·4 ± 1·4 years) underwent a standard 75-g oral glucose tolerance test with blood sampling at 0, 30, 60, 90 and 120 min. Fasting serum glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured.
Results: 57% of the men had normal GT, 30% had impaired GT and 13% had newly diagnosed type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = -4·2 ± 0·3 nm, P < 0·0001). T levels remained suppressed at 120 min compared with baseline (13·7 ± 0·6 vs 16·5 ± 0·7 nm, P < 0·0001) and did not differ across GT or BMI. Of the 66 men with normal T levels at baseline, 10 (15%) had levels that decreased to the hypogonadal range (<9·7 nm) at one or more time points. SHBG, LH and cortisol levels were unchanged. Leptin levels decreased from baseline at all time points (P < 0·0001).
Conclusions: Glucose ingestion induces a significant reduction in total and free T levels in men, which is similar across the spectrum of glucose tolerance. This decrease in T appears to be because of a direct testicular defect, but the absence of compensatory changes in LH suggests an additional central component. Men found to have low nonfasting T levels should be re-evaluated in the fasting state.
Trial registration: ClinicalTrials.gov NCT00433173.
© 2012 Blackwell Publishing Ltd.
Source: PubMed
Prochains essais cliniques
-
NCT07826949Pas encore de recrutementGliome | Tumeur cérébrale | Gliomes récurrents de haut grade
-
NCT07826962Pas encore de recrutementParticipation des patients
-
NCT07826975Pas encore de recrutement
-
NCT07826988Pas encore de recrutementDrépanocytose | Crise vaso-occlusive
-
NCT07827001RecrutementCancer du cerveau | Cancer du SNC | Cancer du système nerveux | Cancer du cerveau métastatique
-
NCT07827027Pas encore de recrutement
-
NCT07827040RecrutementAdultes | Assistance numérique basse vision | Troubles de la vision
-
NCT07827053Pas encore de recrutementAdénocarcinome canalaire pancréatique (PDAC)
-
NCT07827066Pas encore de recrutementSevrage tabagique | Agent IA | Early-Stage Cancer
-
NCT07827131Pas encore de recrutement